Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From ACC.org

Oct 30, 2019

This week's View offers key points to remember from an opinion article on the current diagnostic criteria and differential diagnosis of arrhythmogenic right ventricular cardiomyopathy and a consensus statement on the diagnosis of heart failure (HF) with preserved ejection fraction (EF) and also addresses...


Oct 23, 2019

This week's View summarizes the 10-year follow-up of the SYNTAX trial (Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery) and offers key points to remember from an article about lipid management for the prevention of atherosclerotic cardiovascular disease and a state-of-the-art review on...


Oct 17, 2019

This week's View examines the patterns of treatment changes and consistency of reduced adverse events in patients with stable chest pain undergoing coronary computed tomography angiography, the risk of osteoporotic fractures in patients with atrial fibrillation treated with vitamin K antagonists versus direct...


Oct 9, 2019

This week's View explores the benefit of uninterrupted direct oral anticoagulant versus uninterrupted vitamin K antagonist use for patients undergoing catheter ablation for nonvalvular atrial fibrillation; which therapy, anticoagulation or antiplatelet, is better for preventing stroke recurrence in patients with...


Oct 2, 2019

This week's View takes a look at which patients without known cardiovascular disease are most likely to experience net benefit from aspirin therapy for primary prevention, the outcomes with angioplasty with paclitaxel-coated balloon versus repeat stenting with drug-eluting stent in patients undergoing treatment...